Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease

This cohort study examines the prevalence of contraindications to nirmatrelvir-ritonavir in patients hospitalized with COVID-19.

Detalles Bibliográficos
Autores principales: Hoertel, Nicolas, Boulware, David R., Sánchez-Rico, Marina, Burgun, Anita, Limosin, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667321/
https://www.ncbi.nlm.nih.gov/pubmed/36378313
http://dx.doi.org/10.1001/jamanetworkopen.2022.42140
_version_ 1784831701017427968
author Hoertel, Nicolas
Boulware, David R.
Sánchez-Rico, Marina
Burgun, Anita
Limosin, Frédéric
author_facet Hoertel, Nicolas
Boulware, David R.
Sánchez-Rico, Marina
Burgun, Anita
Limosin, Frédéric
author_sort Hoertel, Nicolas
collection PubMed
description This cohort study examines the prevalence of contraindications to nirmatrelvir-ritonavir in patients hospitalized with COVID-19.
format Online
Article
Text
id pubmed-9667321
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-96673212022-12-05 Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease Hoertel, Nicolas Boulware, David R. Sánchez-Rico, Marina Burgun, Anita Limosin, Frédéric JAMA Netw Open Research Letter This cohort study examines the prevalence of contraindications to nirmatrelvir-ritonavir in patients hospitalized with COVID-19. American Medical Association 2022-11-15 /pmc/articles/PMC9667321/ /pubmed/36378313 http://dx.doi.org/10.1001/jamanetworkopen.2022.42140 Text en Copyright 2022 Hoertel N et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Hoertel, Nicolas
Boulware, David R.
Sánchez-Rico, Marina
Burgun, Anita
Limosin, Frédéric
Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
title Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
title_full Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
title_fullStr Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
title_full_unstemmed Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
title_short Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
title_sort prevalence of contraindications to nirmatrelvir-ritonavir among hospitalized patients with covid-19 at risk for progression to severe disease
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667321/
https://www.ncbi.nlm.nih.gov/pubmed/36378313
http://dx.doi.org/10.1001/jamanetworkopen.2022.42140
work_keys_str_mv AT hoertelnicolas prevalenceofcontraindicationstonirmatrelvirritonaviramonghospitalizedpatientswithcovid19atriskforprogressiontoseveredisease
AT boulwaredavidr prevalenceofcontraindicationstonirmatrelvirritonaviramonghospitalizedpatientswithcovid19atriskforprogressiontoseveredisease
AT sanchezricomarina prevalenceofcontraindicationstonirmatrelvirritonaviramonghospitalizedpatientswithcovid19atriskforprogressiontoseveredisease
AT burgunanita prevalenceofcontraindicationstonirmatrelvirritonaviramonghospitalizedpatientswithcovid19atriskforprogressiontoseveredisease
AT limosinfrederic prevalenceofcontraindicationstonirmatrelvirritonaviramonghospitalizedpatientswithcovid19atriskforprogressiontoseveredisease

Ejemplares similares